Francois Meyer

This inventor holds 5 USPTO granted patents. Top assignees: Medarex Inc., Medisup International, N.v., Laboratoire European De Biotechnologie S.a.. Active years: 1999-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Francois Meyer. Retrieved from https://idiyas.com/inventor/francois-meyer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5

% Patents Active = 60.0

Average Co-Inventor Count = 5.3

ph-index = 5

Forward Citations = 97(Granted Patents)

Location History:

Villejuif, FR (2002)
Paris, FR (1999 - 2008)

Company Filing History:

Medisup International, N.v.

patents

1 out of 1

Laboratoire European De Biotechnologie S.a.

patent

Years Active: 1999-2008

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7465451 - Monoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferon (2008-12-16),

2. 7179465 - Monoclonal antibodies against the interferon receptor, with neutralizing activity against type 1 interferon (2007-02-20),

3. 6787634 - Isolated peptide or polypeptide of the extracellular portion of the human interferon receptor (IFN-R). (2004-09-07),

4. 6475983 - Water-soluble polypeptides having a high affinity for &agr; and &bgr; interferons (2002-11-05),

5. 5919453 - Monoclonal antibodies against the interferon receptor, with neutralizing (1999-07-06),

Title: The Innovations of Francois Meyer

Introduction

Francois Meyer is a notable inventor based in Paris, France. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 5 patents, his work has had a considerable impact on medical research and diagnostics.

Latest Patents

Meyer’s latest patents include groundbreaking inventions related to monoclonal antibodies against the interferon receptor. These antibodies are characterized by their ability to recognize the extracellular domain of the human interferon class I receptor (IFN-R). They possess a neutralizing capacity against the biological properties of human type I interferon, making them valuable for diagnostic purposes.

Career Highlights

Throughout his career, Francois Meyer has worked with several prominent companies in the biotechnology sector. Notable among these are Medisup International and Medarex Inc. His experience in these organizations has allowed him to refine his expertise and contribute to innovative solutions in the field.

Collaborations

Meyer has collaborated with esteemed colleagues such as Michael Gerard Tovey and Patrick Benoit. These partnerships have fostered a collaborative environment that has led to significant advancements in their shared field of research.

Conclusion

Francois Meyer’s contributions to the field of biotechnology, particularly through his patents on monoclonal antibodies, highlight his role as an influential inventor. His work continues to pave the way for advancements in medical diagnostics and treatment.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]